Complete remission with tyrosine kinase inhibitors in renal cell carcinoma. [electronic resource]
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology Feb 2012
- 482-7 p. digital
Publication Type: Journal Article; Multicenter Study
1527-7755
10.1200/JCO.2011.37.2516 doi
Adult Aged Antineoplastic Agents--therapeutic use Benzenesulfonates--therapeutic use Carcinoma, Renal Cell--drug therapy Feasibility Studies Female Humans Indoles--therapeutic use Kidney Neoplasms--drug therapy Male Medical Records Middle Aged Molecular Targeted Therapy Nephrectomy Niacinamide--analogs & derivatives Phenylurea Compounds Protein Kinase Inhibitors--therapeutic use Protein-Tyrosine Kinases--antagonists & inhibitors Pyridines--therapeutic use Pyrroles--therapeutic use Remission Induction Retrospective Studies Sorafenib Sunitinib Surveys and Questionnaires Treatment Outcome